Workflow
Intuitive Surgical (ISRG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ISRGIntuitive(ISRG) ZACKS·2025-04-22 23:05

Core Insights - Intuitive Surgical, Inc. reported a revenue of 2.25billionforthequarterendedMarch2025,reflectingayearoveryearincreaseof19.22.25 billion for the quarter ended March 2025, reflecting a year-over-year increase of 19.2% [1] - The earnings per share (EPS) for the quarter was 1.81, up from 1.50inthesamequarterlastyear,indicatingapositivegrowthtrend[1]ThereportedrevenueexceededtheZacksConsensusEstimateof1.50 in the same quarter last year, indicating a positive growth trend [1] - The reported revenue exceeded the Zacks Consensus Estimate of 2.18 billion by 3.27%, and the EPS also surpassed the consensus estimate of 1.71by5.851.71 by 5.85% [1] Financial Performance Metrics - The installed base of the Da Vinci Surgical System reached 10,189, slightly below the four-analyst average estimate of 10,194 [4] - Revenue from products (instruments, accessories, and systems) was 1.89 billion, exceeding the seven-analyst average estimate of 1.55billion,withayearoveryeargrowthof19.91.55 billion, with a year-over-year growth of 19.9% [4] - Revenue from services amounted to 363 million, surpassing the seven-analyst average estimate of 356.83million,representingayearoveryearincreaseof15.8356.83 million, representing a year-over-year increase of 15.8% [4] - Revenue from systems was reported at 522.70 million, compared to the average estimate of 481.95million,showingayearoveryearchangeof25481.95 million, showing a year-over-year change of 25% [4] - Revenue from instruments and accessories reached 1.37 billion, slightly above the average estimate of $1.33 billion, with an 18% year-over-year increase [4] Stock Performance - Over the past month, shares of Intuitive Surgical have returned -7.9%, compared to a -8.9% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]